(Q42282809)

19 October 2017

Studies of tamoxifen as a promoter of hepatocarcinogenesis in female Fischer F344 rats (English)

1 reference

19 October 2017

1 reference

6

H C Pitot

1 reference

19 October 2017

1

Y P Dragan

1 reference

19 October 2017

5

V C Jordan

1 reference

19 October 2017

S Fahey

2

1 reference

19 October 2017

K Street

series ordinal

3

1 reference

19 October 2017

J Vaughan

series ordinal

4

1 reference

19 October 2017

language of work or name

English

0 references

publication date

1 January 1994

1 reference

Breast Cancer Research and Treatment

19 October 2017

1 reference

19 October 2017

31

1 reference

19 October 2017

11-25

1 reference

19 October 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00689673

19 October 2017

0 references

cites work

Inhibitory effect of tamoxifen on diethylstilbestrol-promoted hepatic tumorigenesis in male rats and its possible mechanism of action

1 reference

https://api.crossref.org/works/10.1007%2FBF00689673

Kinetics of induction and growth of precancerous liver-cell foci, and liver tumour formation by diethylnitrosamine in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00689673

Tamoxifen metabolism: pharmacokinetic and in vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00689673

A comparison of two doses of tamoxifen (Nolvadex) in postmenopausal women with advanced breast cancer: 10 mg bd versus 20 mg bd.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00689673

The initiation-promotion-progression model of rat hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00689673

Tamoxifen, serum lipoproteins and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00689673

Tamoxifen induces hepatocellular carcinoma in rat liver: a 1-year study with two antiestrogens

21 January 2018

1 reference

12 December 2020

The pharmacology and clinical uses of tamoxifen

1 reference

12 December 2020

Regression of liver cell adenomas associated with oral contraceptives

1 reference

12 December 2020

Pharmacology of tamoxifen in laboratory animals.

1 reference

12 December 2020

Effects of ethinyl estradiol and tamoxifen on liver DNA turnover and new synthesis and appearance of gamma glutamyl transpeptidase-positive foci in female rats.

1 reference

12 December 2020

The effects of diethylstilbestrol, tamoxifen, and toremifene on estrogen-inducible hepatic proteins and estrogen receptor proteins in female rats

1 reference

12 December 2020

Structural requirements for the in vitro transformation of Syrian hamster embryo cells by stilbene estrogens and triphenylethylene-type antiestrogens.

1 reference

12 December 2020

A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationships to altered hepatic foci.

1 reference

12 December 2020

Long-term tamoxifen adjuvant therapy in node-positive breast cancer: a metabolic and pilot clinical study

1 reference

12 December 2020

The effect of estradiol-17-phenylpropionate and estradiol benzoate on N-nitrosomorpholine-induced liver carcinogenesis in ovariectomized female rats

1 reference

12 December 2020

A semipurified diet that suppresses phenobarbital promotion of hepatocarcinogenesis in the rat

1 reference

12 December 2020

Two-year carcinogenicity study of tamoxifen in Alderley Park Wistar-derived rats

1 reference

12 December 2020

Long-term tamoxifen therapy for breast cancer

1 reference

12 December 2020

Long-term prophylactic use of tamoxifen: is it safe?

1 reference

12 December 2020

Application of quantitative stereology to the evaluation of enzyme-altered foci in rat liver.

1 reference

12 December 2020

Tamoxifen-induced generalized lipidosis in rats subchronically treated with high doses

1 reference

12 December 2020

Evidence for the hormone dependency of hepatic hyperplastic nodules: inhibition of malignant transformation after exogenous 17 beta-estradiol and tamoxifen.

1 reference

12 December 2020

Oral contraceptive steroids as promoters of hepatocarcinogenesis in female Sprague-Dawley rats

1 reference

12 December 2020

The effect of estrogen and tamoxifen on hepatocyte proliferation in vivo and in vitro

1 reference

12 December 2020

Tamoxifen for breast cancer: associated endometrial cancer

1 reference

12 December 2020

In vivo inhibition of insulin-like growth factor I gene expression by tamoxifen

1 reference

12 December 2020

Hormonal changes during a prolonged tamoxifen treatment in patients with advanced breast cancer

1 reference

12 December 2020

Immunochemical comparison and quantitation of microsomal flavin-containing monooxygenases in various hog, mouse, rat, rabbit, dog, and human tissues

1 reference

12 December 2020

Contrasting Endocrine Activities of cis and trans Isomers in a Series of Substituted Triphenylethylenes

1 reference

12 December 2020

Adjuvant trial of 12 cycles of CMFPT followed by observation or continuous tamoxifen versus four cycles of CMFPT in postmenopausal women with breast cancer: an Eastern Cooperative Oncology Group phase III study

1 reference

12 December 2020

Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer.

1 reference

12 December 2020

A randomized comparison of tamoxifen with surgical oophorectomy in premenopausal patients with advanced breast cancer

1 reference

12 December 2020

Long-term adjuvant tamoxifen in early breast cancer: effect on bone mineral density in postmenopausal women

1 reference

12 December 2020

Long term effects of tamoxifen. Biological effects of Tamoxifen Working Party

1 reference

12 December 2020

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women.

1 reference

12 December 2020

Tamoxifen as a potential preventive agent in healthy postmenopausal women

1 reference

12 December 2020

Tamoxifen and benign breast problems

1 reference

12 December 2020

Enhancement in rats by the liver tumor promoter ethinyl estradiol of a serum factor(s) which is stimulatory for hepatocyte DNA synthesis

1 reference

12 December 2020

Prevention of breast cancer with tamoxifen--an update on the Royal Marsden Hospital pilot programme

1 reference

12 December 2020

Report of a workshop on classification of specific hepatocellular lesions in rats

1 reference

12 December 2020

The use of beta-galactosidase as a tracer in immunocytochemistry

1 reference

12 December 2020

Anti-oestrogen Therapy for Breast Cancer: A Trial of Tamoxifen at Two Dose Levels

1 reference

12 December 2020

Induction of a pleiotropic response by phenobarbital and related compounds. Response in various inbred strains of rats, response in various species and the induction of aldehyde dehydrogenase in Copenhagen rats

1 reference

12 December 2020

Identification of the cytochrome P450 IIIA family as the enzymes involved in the N-demethylation of tamoxifen in human liver microsomes

1 reference

12 December 2020

Quantitative stereological evaluation of four histochemical markers of altered foci in multistage hepatocarcinogenesis in the rat.

1 reference

12 December 2020

A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474

1 reference

12 December 2020

Distinctive biochemical pattern associated with resistance of hepatocytes in hepatocyte nodules during liver carcinogenesis

1 reference

12 December 2020

An initiation-promotion assay in rat liver as a potential complement to the 2-year carcinogenesis bioassay

1 reference

12 December 2020

Should healthy women take tamoxifen?

1 reference

12 December 2020

Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment

1 reference

12 December 2020

Distribution of tamoxifen and its metabolites in rat and human tissues during steady-state treatment.

1 reference

12 December 2020

Project of experimental bioassays on chemoprevention agents performed at the Bologna Institute of Oncology: report on tamoxifen control of spontaneous mammary tumors on Sprague-Dawley rats

1 reference

12 December 2020

A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies

1 reference

12 December 2020

Potential role of tamoxifen in prevention of breast cancer

1 reference

12 December 2020

Tamoxifen--panacea or Pandora's box?

1 reference

12 December 2020

Comparative effects of estrogen and antiestrogen on plasma renin substrate levels and hepatic estrogen receptors in the rat

1 reference

12 December 2020

Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers

1 reference

12 December 2020

Randomized trial of bilateral oophorectomy versus tamoxifen in premenopausal women with metastatic breast cancer

1 reference

12 December 2020

Mitogens and hepatocyte growth control in vivo and in vitro.

1 reference

12 December 2020

Biochemical characterisation of stages of hepatocarcinogenesis after a single dose of diethylnitrosamine

1 reference

12 December 2020

Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57BL/6 mice and in human MCL-5 cells

1 reference

12 December 2020

Dietary effects on initiation and promotion of hepatocarcinogenesis in rat.

1 reference

12 December 2020

Role of estrogens as promoters of hepatic neoplasia

1 reference

12 December 2020

Long-term tamoxifen therapy to control or to prevent breast cancer: laboratory concept to clinical trials

1 reference

12 December 2020

Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase

1 reference

12 December 2020

Application of quantitative stereology to the evaluation of phenotypically heterogeneous enzyme-altered foci in the rat liver

1 reference

12 December 2020

Role of P-450c in the formation of a reactive intermediate of chlorotrianisene (TACE) by hepatic microsomes from methylcholanthrene-treated rats

1 reference

12 December 2020

Cytochrome P-450-mediated activation and irreversible binding of the antiestrogen tamoxifen to proteins in rat and human liver: possible involvement of flavin-containing monooxygenases in tamoxifen activation

1 reference

12 December 2020

Induction of CYP2B1 and 3A1, and associated monoxygenase activities by tamoxifen and certain analogues in the livers of female rats and mice.

1 reference

12 December 2020

Tumor promotion as a target for estrogen/antiestrogen effects in rat hepatocarcinogenesis

1 reference

12 December 2020

Antiestrogen-induced remissions in premenopausal women with stage IV breast cancer: effects on ovarian function

1 reference

12 December 2020

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

1 reference

12 December 2020

Tamoxifen and non-malignant indications

1 reference

12 December 2020

Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient

1 reference

12 December 2020

Endocrine pharmacology of antiestrogens as antitumor agents

1 reference

12 December 2020

Long-term adjuvant tamoxifen therapy for breast cancer

1 reference

12 December 2020

Characterization of histochemically detectable altered hepatocyte foci and their relationship to hepatic tumorigenesis in rats treated once with diethylnitrosamine or benzo(a)pyrene within one day after birth.

1 reference

12 December 2020

Tamoxifen metabolites in patients on long-term adjuvant therapy for breast cancer

1 reference

12 December 2020

Prolonging tamoxifen therapy for primary breast cancer. Findings from the National Surgical Adjuvant Breast and Bowel Project clinical trial

1 reference

12 December 2020

Non-genomic effects of estrogens and antiestrogens

1 reference

12 December 2020

An approach to the development of a short-term whole-animal bioassay to distinguish initiating agents (incomplete carcinogens), promoting agents, complete carcinogens, and noncarcinogens in rat liver.

1 reference

12 December 2020

A comparative study of the estrogenic effects of tamoxifen and 17 beta-estradiol in postmenopausal women

1 reference

12 December 2020

Increases in steroid binding globulins induced by tamoxifen in patients with carcinoma of the breast

1 reference

12 December 2020

Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse

1 reference

12 December 2020

Monooxygenase-mediated activation of chlorotrianisene (TACE) in covalent binding to rat hepatic microsomal proteins

1 reference

12 December 2020

Adjuvant tamoxifen in postmenopausal breast cancer: preliminary results of a randomized trial

1 reference

12 December 2020

Role and mechanism of action of tamoxifen in premenopausal women with metastatic breast carcinoma

1 reference

12 December 2020

Induction of covalent DNA adducts in rodents by tamoxifen.

1 reference

12 December 2020

Determination of tamoxifen and metabolites in human serum by high-performance liquid chromatography with post-column fluorescence activation

1 reference

12 December 2020

Evaluation of tamoxifen dose in advanced breast cancer: a progress report

1 reference

12 December 2020

Induction and promotion of gamma-glutamyltranspeptidase-positive foci in the liver of female rats treated with ethinyl estradiol, clomiphene, tamoxifen and their associations

1 reference

12 December 2020

The triphenylethylene drug tamoxifen is a strong liver carcinogen in the rat.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00689673

1 reference

Dimensions Publication ID

19 October 2017

0 references

1 reference